-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Editas Medicine (EDIT)
-
-
-
-
-
-
-
Verve Therapeutics takeover has 'positive readthrough' for gene editing space - BMO Capital
-
-
-
-
-
-
-
Editas Medicine (EDIT) call put ratio 5.1 calls to 1 put on active option volume of 30K contracts
-
-
-
-
-
-
-
Stifel Downgrades Editas Medicine (EDIT) to Hold
-
-
-
-
-
-
-
Chardan Capital Markets Reiterates Buy Rating on Editas Medicine (EDIT)
-
-
-
-
-
-
-
Editas Medicine (EDIT) PT Lowered to $10 at Baird
-
-
-
-
-
-
-
Pre-Open Stock Movers 06/28: (NTLA) (AVXL) (EDIT) Higher; (GTEC) (XPO) (CCL) Lower (more...)
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

